Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 37% ± 21% | |
lung | 8 studies | 27% ± 10% | |
peripheral blood | 8 studies | 22% ± 8% | |
eye | 5 studies | 31% ± 22% | |
heart | 5 studies | 35% ± 10% | |
liver | 5 studies | 28% ± 9% | |
adipose | 4 studies | 33% ± 10% | |
kidney | 3 studies | 23% ± 4% | |
intestine | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 7537.18 | 2642 / 2642 | 100% | 49.41 | 705 / 705 |
breast | 100% | 5675.57 | 459 / 459 | 100% | 42.00 | 1118 / 1118 |
esophagus | 100% | 4048.38 | 1445 / 1445 | 100% | 36.30 | 183 / 183 |
lung | 100% | 5677.27 | 578 / 578 | 100% | 32.05 | 1155 / 1155 |
prostate | 100% | 4922.49 | 245 / 245 | 100% | 53.02 | 502 / 502 |
uterus | 100% | 5722.10 | 170 / 170 | 100% | 27.74 | 458 / 459 |
thymus | 100% | 4979.65 | 653 / 653 | 100% | 38.97 | 603 / 605 |
ovary | 100% | 5015.87 | 180 / 180 | 100% | 24.06 | 428 / 430 |
bladder | 100% | 4464.95 | 21 / 21 | 99% | 29.19 | 501 / 504 |
kidney | 100% | 3584.02 | 89 / 89 | 99% | 32.14 | 895 / 901 |
skin | 100% | 5350.43 | 1808 / 1809 | 99% | 50.15 | 466 / 472 |
intestine | 100% | 4571.76 | 966 / 966 | 99% | 25.84 | 520 / 527 |
adrenal gland | 100% | 7288.20 | 258 / 258 | 98% | 27.77 | 226 / 230 |
stomach | 100% | 3313.46 | 359 / 359 | 98% | 28.37 | 280 / 286 |
liver | 100% | 1953.93 | 225 / 226 | 97% | 17.55 | 395 / 406 |
pancreas | 94% | 1855.38 | 308 / 328 | 99% | 32.79 | 176 / 178 |
adipose | 100% | 6387.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 6310.28 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 57.76 | 29 / 29 |
muscle | 100% | 5218.65 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5755.92 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 20.48 | 1 / 1 |
heart | 97% | 3463.07 | 835 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 31.69 | 76 / 80 |
peripheral blood | 94% | 4560.12 | 873 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001921 | Biological process | positive regulation of receptor recycling |
GO_0006897 | Biological process | endocytosis |
GO_0098884 | Biological process | postsynaptic neurotransmitter receptor internalization |
GO_0032456 | Biological process | endocytic recycling |
GO_0046718 | Biological process | symbiont entry into host cell |
GO_0048268 | Biological process | clathrin coat assembly |
GO_0016197 | Biological process | endosomal transport |
GO_0016050 | Biological process | vesicle organization |
GO_0019065 | Biological process | receptor-mediated endocytosis of virus by host cell |
GO_0015031 | Biological process | protein transport |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0006895 | Biological process | Golgi to endosome transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0031901 | Cellular component | early endosome membrane |
GO_0098794 | Cellular component | postsynapse |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0005829 | Cellular component | cytosol |
GO_0030132 | Cellular component | clathrin coat of coated pit |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0016235 | Cellular component | aggresome |
GO_0045296 | Molecular function | cadherin binding |
GO_0031593 | Molecular function | polyubiquitin modification-dependent protein binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0017124 | Molecular function | SH3 domain binding |
Gene name | EPS15 |
Protein name | Epidermal growth factor receptor pathway substrate 15 Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p) KMT2A |
Synonyms | KMT2A AF1P fusion |
Description | FUNCTION: Involved in cell growth regulation. May be involved in the regulation of mitogenic signals and control of cell proliferation. Involved in the internalization of ligand-inducible receptors of the receptor tyrosine kinase (RTK) type, in particular EGFR. Plays a role in the assembly of clathrin-coated pits (CCPs). Acts as a clathrin adapter required for post-Golgi trafficking. Seems to be involved in CCPs maturation including invagination or budding. Involved in endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR); internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to require association with DAB2. . |
Accessions | ENST00000706288.1 ENST00000706287.1 ENST00000706293.1 B1AUU8 ENST00000493793.2 [P42566-2] A0A994J841 ENST00000371730.6 ENST00000706292.1 A0A994J7R8 ENST00000465467.1 A0A994J5J3 A0A994J5W4 P42566 ENST00000371733.8 [P42566-1] ENST00000706291.1 A0A994J5A3 A0A4D6WHI2 S4R3U1 |